Recruitment unclearEUCTR 2019-001621-27
A pilot study on oral s-ketamine for depression and demoralization in patients with advanced cancer receiving palliative care
This historical record does not confirm current site availability.
Historical research recordNetherlands
Understand this study
What is this study about?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
- Listed locations
- Netherlands
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This is historical registry information. What is the current study status and protocol?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Recruitment unclear
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- University Medical Center Groningen
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Netherlands
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2019-001621-27
- Official title
Show the full official title
A pilot study on oral s-ketamine for depression and demoralization in patients with advanced cancer receiving palliative care
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Netherlands
Registry details
Historical country statuses
- Netherlands — Ongoing
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Medical Center Groningen, a hospital or academic medical center.
